Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials

Reference

D. Eyding, M. Lelgemann, U. Grouven, M. Harter, M. Kromp, T. Kaiser, M. F. Kerekes, M. Gerken, B. Wieseler “Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials” (2010) DOI: 10.1136/bmj.c4737

@Article{eyding2010,
  title = {Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials},
  volume = {341},
  issn = {1468-5833},
  url = {http://dx.doi.org/10.1136/bmj.c4737},
  doi = {10.1136/bmj.c4737},
  number = {oct12 1},
  journal = {BMJ},
  publisher = {BMJ},
  author = {Eyding, D. and Lelgemann, M. and Grouven, U. and Harter, M. and Kromp, M. and Kaiser, T. and Kerekes, M. F. and Gerken, M. and Wieseler, B.},
  year = {2010},
  month = {oct},
  pages = {c4737–c4737}
}